Edwin Tucker
Technik-/Wissenschafts-/F&E-Leiter bei JASPER THERAPEUTICS, INC.
Vermögen: - $ am 30.04.2024
Aktive Positionen von Edwin Tucker
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| JASPER THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 12.06.2023 | - |
| The Royal College of Physicians | Corporate Officer/Principal | - | - |
Karriereverlauf von Edwin Tucker
Ehemalige bekannte Positionen von Edwin Tucker
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MIRUM PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 28.10.2019 | 01.11.2021 |
| Acerta Pharma LLC | Compliance Officer | 01.01.2015 | 01.01.2018 |
| Geschäftsführer | 01.01.2015 | 01.01.2019 | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01.01.2013 | 01.01.2015 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | 01.01.2010 | 01.01.2013 |
Goldfinch Bio, Inc.
 Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Goldfinch Bio, Inc. operates as a biotechnology company. It focuses on discovering and developing precision therapies for patients with kidney disease. The firm develops and manufactures medicines. The company was founded by Joseph Vincent Bonventre, Anna Greka, Fridhelm Hildebrandt, Daniel MacArthur, Stefan Somlo and Peter Mundel in December 2016 and is headquartered in Cambridge, MA. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Edwin Tucker
| University of Leeds | Doctorate Degree |
| University of Connecticut | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 8 |
| Vereinigtes Königreich | 3 |
Operativ
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 4 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| MIRUM PHARMACEUTICALS, INC. | Health Technology |
| JOHNSON & JOHNSON | Health Technology |
| JASPER THERAPEUTICS, INC. | Finance |
| Private Unternehmen | 3 |
|---|---|
| Acerta Pharma LLC | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Goldfinch Bio, Inc.
Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Goldfinch Bio, Inc. operates as a biotechnology company. It focuses on discovering and developing precision therapies for patients with kidney disease. The firm develops and manufactures medicines. The company was founded by Joseph Vincent Bonventre, Anna Greka, Fridhelm Hildebrandt, Daniel MacArthur, Stefan Somlo and Peter Mundel in December 2016 and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Edwin Tucker
- Erfahrung
